Comparison of a new desktop spirometer (Spirospec) with a laboratory spirometer in a respiratory out-patient clinic

dc.contributor.authorSwart F.
dc.contributor.authorSchuurmans M.M.
dc.contributor.authorHeydenreich J.C.
dc.contributor.authorPieper C.H.
dc.contributor.authorBolliger C.T.
dc.date.accessioned2011-05-15T16:17:53Z
dc.date.available2011-05-15T16:17:53Z
dc.date.issued2004
dc.description.abstractBACKGROUND: The performance of spirometers is often evaluated under ideal conditions with computergenerated waveforms or in vivo testing with healthy subjects. Real-life conditions are less ideal because of comorbidities, age of the subjects, and a variety of air flow limitations. Evaluation of new spirometry equipment can also be performed under these less favorable conditions. The Spirospec is a new desktop spirometer that is commercially available, but its accuracy has not been evaluated in a clinical setting. OBJECTIVE: Test the Spirospec with subjects with normal and pathologic pulmonary function. METHODS: A group of 45 patients (mean age 38.4 years, 27 male) booked for evaluation in the pulmonary function laboratory of a tertiary care university hospital were tested with both a Spirospec and a standard Jaeger Masterlab 4.0 spirometer, according to the guidelines of the American Thoracic Society. Three subgroups (normal spirometry, obstructive air flow limitation, and restrictive air flow limitation) of 15 consecutive subjects each underwent spirometry. RESULTS: Pulmonary function measurements from the Spirospec correlated closely (r = 0.95-0.99) with those from the Masterlab 4.0, showing good limits of agreement and differences between the 2 devices: forced vital capacity 0.03 L, forced expiratory volume in the first second (FEV1) -0.01 L, peak expiratory flow -0.41 L/s, peak inspiratory flow 0.43 L/s, forced expiratory flow at 50% of total lung capacity 0.13 L/s, and forced expiratory flow at 75% of total lung capacity 0.12 L/s. With the exception of forced vital capacity and FEV1, these differences were statistically significant (p < 0.05). CONCLUSION: The Spirospec is comparable to the Masterlab 4.0, with high accuracy for FEV1 and forced vital capacity and clinically acceptable differences in the measured flow variables. © 2003 Daedalus Enterprises.
dc.description.versionArticle
dc.identifier.citationRespiratory Care
dc.identifier.citation48
dc.identifier.citation6
dc.identifier.issn00201324
dc.identifier.urihttp://hdl.handle.net/10019.1/14412
dc.subjectadult
dc.subjectairway obstruction
dc.subjectarticle
dc.subjectclinical article
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectdiagnostic accuracy
dc.subjectfemale
dc.subjectforced expiratory volume
dc.subjecthuman
dc.subjectintermethod comparison
dc.subjectlung capacity
dc.subjectlung function
dc.subjectmale
dc.subjectmedical society
dc.subjectoutpatient department
dc.subjectpeak expiratory flow
dc.subjectpractice guideline
dc.subjectrandomized controlled trial
dc.subjectrespiratory care
dc.subjectspirometer
dc.subjectstatistical significance
dc.subjecttertiary health care
dc.subjectuniversity hospital
dc.subjectaged
dc.subjectbreathing disorder
dc.subjectcomparative study
dc.subjectevaluation
dc.subjecthospital information system
dc.subjectinstrumentation
dc.subjectlung function test
dc.subjectmiddle aged
dc.subjectpathophysiology
dc.subjectreproducibility
dc.subjectspirometry
dc.subjectAdult
dc.subjectAged
dc.subjectEvaluation Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectOutpatient Clinics, Hospital
dc.subjectPoint-of-Care Systems
dc.subjectReproducibility of Results
dc.subjectRespiration Disorders
dc.subjectRespiratory Function Tests
dc.subjectSpirometry
dc.titleComparison of a new desktop spirometer (Spirospec) with a laboratory spirometer in a respiratory out-patient clinic
dc.typeArticle
Files